Introduction
Gastric cancer is thought to involve a combination of environmental factors and an accumulation of specifi c genetic alterations, which lead to the progressive disturbance of cell growth and differentiation control. The disease occurs predominantly in older patients, with a peak of incidence in patients who are more than 60 years old [1] [2] [3] .
Several studies have addressed the characteristics of this neoplasia in young patients, suggesting the clinicopathological and biological characteristics in young patients differ in many ways from gastric carcinoma in older patients. For young patients, the male : female ratio is approximately equal [3] or shows female predominance [4, 5] , and the tumors are usually poorly differentiated, diffuse-type or infi ltrative carcinomas [6] [7] [8] . Some authors have suggested that young patients have a worse prognosis, mainly due to the delay in diagnosis and more aggressive tumor behavior [6, 7, 9, 10] , whereas others have shown no difference in survival between young and older patients [11, 12] . Also, young patients are thought to develop carcinomas with a molecular genetic profi le that is distinct from that of sporadic carcinomas occurring at a later age [13] [14] [15] .
A better understanding of the molecular differences between gastric carcinomas affecting young and old patients would allow us to investigate specifi c mole cular biomarkers that could be involved in early gastric carcinogenesis, and the identifi cation of such markers could then improve early diagnosis for specifi c groups.
Several studies have shown considerable interest in the infl uence of cell adhesion molecules such as Ecadherin and β-catenin, and also the mucins, in the development and progression of gastric tumors. Previous results from our group showed, through gene expression analyses using cDNA microarrays, that a large series of genes, including E-cadherin and MUC6 gene expression, were differently expressed in gastric carcinomas [16] .
E-cadherin is a transmembrane calcium-dependent cell adhesion molecule which plays an important role in the maintenance of intercellular adhesion, cell polarity, and mucosal architecture [17, 18] . Functional cadherindependent cell adhesion requires the formation of complexes between E-cadherin and cytoplasmic proteins known as the catenins (e.g., β-catenin). β-Catenin is a multifunctional protein which plays an important role in Wingless/Wnt signaling transduction, in addition to its function as a cell-adhesion molecule [19] . Nuclear β-catenin expression was correlated with poor prognosis in several malignances [20] . Impairment of one or more components of this complex is associated with poor differentiation, dysfunction of intercellular adhesion, increased invasiveness of carcinomas [18, 21] , and tumor progression and metastasis [22] . E-cadherin (CDH1) gene mutations have been associated with familial gastric cancer [23] [24] [25] [26] [27] . Not only E-cadherin gene alterations but also structural abnormalities and/or catenin dysfunction cause disruption of the E-cadherinmediated cell adhesion system [19] .
Mucins are the major component of the mucous gel that covers the surface of epithelial tissue, and at least 13 mucins have been found [28] . It has been suggested that alterations in mucin expression may contribute to cancer invasion and metastatic capabilities through changes in cancer-cell growth regulation, immune recognition, and cellular adhesion [29] [30] [31] . The process of neoplastic transformation in the stomach has been reported to be associated with the decreased expression of mucins that are normally expressed in gastric mucosa (including MUC1, MUC5AC, and MUC6) and with the de novo expression of mucins (e.g., MUC2) that are normally expressed in other organs [32, 33] .
The present study represents a retrospective analysis of patients with gastric carcinoma, carried out in order to compare the clinicopathological features and overall survival between two groups of patients divided by age (≤40 and >40 years of age) and analyze whether differences exist between young and older patients in the expression of markers considered to be important in conventional gastric carcinogenesis, such as E-cadherin, β-catenin, and the mucins MUC1, MUC2, MUC5AC, and MUC6.
Patients, materials, and methods

Patients
This was a retrospective study of the tumor registry of patients who were admitted to the Hospital AC Camargo (São Paulo, Brazil) for the management of adenocarcinoma of the stomach between 1988 and 2005. A total of 515 patients were identifi ed during the study period, and the clinicopathological features of these patients, including information on each patient's age, sex, tumor size, tumor location, histological tumor type, nodal involvement, and stage were reviewed. Tumor size was categorized according the mean size of all tumors (≤5 cm and >5 cm) and tumor location was categorized as being in proximal or distal regions. Histologically, tumors were classifi ed into three main groups: intestinal-type, diffuse-type, and mixed/unclassifi ed-type gastric adenocarcinomas, according to the Laurén histological classifi cation [34] . Pathological stage was classifi ed according to the International Union Against Cancer (UICC) tumor-node-metastasis system (TNM) and it was categorized as early (stages I and II) and advanced (stages III and IV) for statistical analyses. The follow-up data were obtained from the hospital records. Overall survival was defi ned as the time elapsed between primary treatment and death from gastric cancer or from other causes.
Tissue microarray method and immunohistochemistry
Formalin-fi xed, paraffi n wax-embedded tissues from 515 gastric carcinomas were retrieved from the archival tissue bank of the Department of Anatomic Pathology. A section from each specimen was stained with hematoxylin and eosin (H&E) for histological evaluation and the selection of morphologically representative sites in the tumors to construct tissue microarray (TMA) blocks. Our series included 470 cases from TMA blocks (including 17 cases from young patients) and another 45 cases analyzed in conventional sections (including 6 tumorderived biopsies from young patients). For TMA block construction, tissue core biopsies (diameter, 0.6 mm) were punched from selected regions of donor paraffi nembedded tumor blocks and precisely arrayed into a new recipient paraffi n block, using a precision instrument (Beecher Instruments, Silver Spring, MD, USA). Published studies on TMAs have reported the comparability of immunohistochemical results from TMAs versus corresponding large sections [35, 36] . These studies found that the analysis of two cores provided representative information, as compared with the corresponding whole-tissue section. In the present study, all the cases were spotted twice in each TMA block and immunohistochemistry was carried out in two slides at different depth levels, to increase the accuracy and the strength of the array-based data. Immunohistochemical analysis was performed in 3-μm-thick sections from each sample of TMA block and conventional blocks by the standard streptavidin-biotin peroxidase technique. Briefl y, tissue sections were deparaffi nized and rehydrated, and antigen retrieval was performed by placing the tissue sections in citrate buffer (0.01 M, pH 6.0) in a pressure cooker. Endogenous peroxidase was blocked using 3% hydrogen peroxide and then the sections were washed with phosphate-buffered saline (PBS), pH 7.4. The sections were incubated with a primary mouse monoclonal antibody overnight at 4 °C: E-cadherin (1: 750; BD Transduction, San Jose, CA, USA); β-catenin (1: 1000; BD Transduction); all mucins, by Novocastra (New Castle, UK); MUC1 [1: 500], MUC2 [1: 1000], MUC5AC [1: 500], and MUC6 [1: 600]). Then, the sections were incubated for 30 min at room temperature with biotinylated secondary antibodies (K492; DAKO, Copenhagen, Denmark), followed by three washes in PBS and incubation with 3, 3-diaminobenzidine-tetrahydrochloride solution for 5 min. The sections were counterstained with hematoxylin. For negative control preparations, the primary antibodies were omitted from the reaction sequence.
The expression of E-cadherin and β-catenin in malignant cells was compared with that in nonmalignant cells. Only a membranous pattern, which was stained as strongly as normal epithelial cells, was considered to be normal. In contrast, an absent pattern (loss of staining), a cytoplasmic pattern (cytoplasmic staining with loss of membranous expression), and a heterogeneous pattern (cytoplasmic staining with preservation of membranous expression) were categorized as altered patterns [21] . Nuclear staining of β-catenin was also categorized as an altered pattern. In the case of mixed patterns in some sections, the classifi cation was based on the dominant pattern. The expression of the mucins MUC1, MUC2, MUC5AC, and MUC6 was considered positive if at least 10% of the neoplastic cells were stained [37] .
Statistical analysis
All statistical analyses were performed using the SPSS 13.0 statistical software program (SPSS, Chicago, IL, USA). The χ 2 test and Fisher's exact test were used to analyze the association between age and clinicopathological parameters and molecular biomarker expression. Five-year survival rates were estimated using the Kaplan-Meier method, and the log-rank test was used to compare the curves. The Cox proportional hazards model was performed to fi nd the independent risk factors for death. For all tests, the alpha error was set at 5%.
Results
A total of 515 patients with gastric adenocarcinomas were divided into two groups according to their age: young (age ≤40 years; n = 62) and older patients (age >40 years; n = 453). Of the 62 young patients (mean age, 35 years), 38 (61.3%) were 35 years old or younger, and 20 (32.2%) were less than 30 years old. Table 1 summarizes the clinicopathological fi ndings of gastric carcinoma in the 515 patients divided by age (≤40 years vs >40 years old). The young and older patients had similar distributions with respect to sex, tumor location, and stage (P > 0.05). There were some differences in distributions related to tumor size and lymph node metastasis, but the differences did not reach statistical signifi cance. According to Laurén's histological classifi cation [34] , the young group had a significantly higher percentage of diffuse-type tumor than the older group (P < 0.01).
Representative immunohistochemistry staining for marker expression pattern in the gastric cancer can be seen in Figs. 1-3. As shown in Table 2 , alterations in the E-cadherin/β-catenin adhesion complex patterns occurred in a high percentage of gastric carcinomas in both groups of patients: 73% of all evaluated samples presented are altered E-cadherin (absent/reduced) expression pattern, and 91% of all samples showed an altered β-catenin expression pattern. The rate of Ecadherin preserved membranous expression was higher in the young group than in the older group (P < 0.01). Concerning β-catenin pattern expression, a similar situation occurred -the young group showed a higher preservation of membranous β-catenin expression (P < 0.01). Comparison of the expression rates of each mucin in the carcinomas of the young and older patients showed that positivity for MUC2, MUC5AC, and MUC6 was higher in young patients with gastric carcinoma when compared with the older group (P < 0.01). No signifi cant difference was seen between the positivity rates for MUC1 in the two groups (see Fig. 3A -H for the mucin expression patterns). Follow-up ranged from 1 day to 177.5 months, with a mean follow-up of 20 months. When the survival analysis was restricted to the young patient group, only the stage persisted as a prognostic factor. However, univariate analysis of survival for all patients (Table 3) showed that patients with proximal tumor location, larger tumor size (>5 cm), lymph node metastasis, advanced-stage disease (all P < 0.01), and MUC6 negativity (P = 0.01) had a worse survival rate, as seen in Fig. 4 . Sex, histological tumor type, and the expression patterns of E-cadherin, β-catenin, MUC1, MUC2, and MUC5AC were not signifi cant prognostic factors for patients with gastric carcinomas (P > 0.05). Of interest, the young patients with gastric carcinoma had a better 5-year survival rate than the older patients (P = 0.02) according to the univariate analysis, as seen in Fig. 4 (the age graphic). But multivariate analysis ( Table 4 ) confi rmed that only the stage of disease, tumor location, and tumor size were independent risk factors for death. This analysis also showed that age itself was not an independent prognostic survival factor for patients with gastric cancer.
Discussion
There are controversies about whether gastric cancer in young patients differs in any way from gastric cancer in older patients. Young patients with gastric cancer are believed to have more aggressive disease and a poorer prognosis than older patients [7] . A comparative study from Japan demonstrated different features of gastric cancer in patients younger than 40 years compared with those in patients older than 70 years. In patients older than 70 years, tumors were smaller and less infi ltrative, and differentiated lesions were more common in comparison to fi ndings in the patients younger than 40 years [38] . 4 . Five-year overall survival according to the stage (P < 0.01), location of the disease (P < 0.01), tumor size (P < 0.01), lymph node status (P < 0.01), MUC6 expression (P = 0.01), and age (P = 0.02) In our series, there was a male predominance in both age groups, and there was no signifi cant difference in male-female distribution between the young and older patients, as reported previously [12] . In regard to the tumor location, the frequency of tumors located in proximal and distal regions in our study was similar in the young and older patients (P = 0.96), although some authors have found that the upper third of the stomach was more frequently involved in young patients [11] . We found that young patients were more likely to present with smaller tumors (≤5 cm) than older patients, but the difference did not reach statistical signifi cance.
Diffuse histology has consistently been shown to be associated with a young age at diagnosis [3, 11] . In accordance with previous reports, we found that significantly more young patients had diffuse histology than intestinal or mixed histology, while gastric carcinoma in the older group was usually the intestinal type (P < 0.01). This correlation between age and intestinal type, which has been associated with precursor changes described by the multistep carcinogenesis model as a sequential chain of events characterized as chronic gastritis, atrophy, intestinal metaplasia, dysplasia, and carcinoma [39] , involves environmental factors. However, the predominance of diffuse-type tumors in young patients suggests an association with genotypic events involving E-cadherin gene mutation in the gastric neoplastic process.
In our series, 75% of all patients presented with nodepositive disease. It was expected that as the young group presented with a higher frequency of diffuse-type tumor, this also could represent an increased rate of isolated cells infi ltrating the gastric wall and a higher frequency of lymph node metastasis; however, there were no signifi cant differences in lymph node metastasis between the two groups (P = 0.05) [11] . In our casuistic, approximately 68% of all patients presented with advanced tumor stage at diagnosis, and no signifi cant differences were found between the two groups in the frequency of early and advanced stage.
Regarding the tested markers, we observed that alterations in E-cadherin/β-catenin adhesion complex expression occured in a considerable proportion of gastric carcinomas in both groups of patients (≤40 years vs >40 years). The E-cadherin expression pattern has been associated with histological tumor type [40, 41] and it has been suggested that loss of E-cadherin is a crucial defect in diffuse-type tumors, and this could explain the observed phenotype of noncohesive cells [42] . According to this correlation between histological type and cadherin-catenin adhesion system expression, it was expected that, as the young group presented with a higher proportion of diffusetype tumors, this group could also present with a higher frequency of alterations in the cadherin/catenin complex compared to the older group. However, in our patients, the young group presented with a significantly higher percentage of the membranous expression pattern of the adhesion system complex when compared to fi ndings in the older group (42.6% vs 25.1% for E-cadherin, and 32.8% vs 6.0% for β-catenin; both P < 0.01).
We observed some cases of diffuse-type gastric carcinomas displaying E-cadherin and β-catenin mem branous expression (Figs. 1B and 2C) , and some intestinal-type tumors lacking the expression of these markers (Fig.  1C) . These fi ndings strongly suggest that, in some cases, the presence of E-cadherin, as revealed by immunohistochemistry, might not indicate that E-cadherin is necessarily functional. We might consider that E-cadherin interacts with other proteins, such as APC, c-erbB-2, and p120 (not included in this study), and that alterations in these proteins interacting with the cadherincatenin system may affect its adhesive function, despite the expression of E-cadherin and β-catenin being normal [40, [43] [44] [45] . Another possibility might be a functional defect of E-cadherin with normal immunohistochemical expression, as has been shown to occur in diffuse-type gastric cancer due to exon skipping in the E-cadherin gene [46] . Nuclear expression of β-catenin was observed in both groups, but the molecular mechanisms leading to the activation of the Wnt/β-catenin signaling pathway still have to be elucidated in our series. Some authors have reported correlations between the E-cadherin expression pattern and prognosis [47] [48] [49] , in contrast to the reports of others [40, 50] . According to our data, no correlations were found between E-cadherin and β-catenin expression and prognosis.
Several groups have studied the correlation between MUC1 gene expression, clinicopathological features, and the prognoses of patients with breast, pancreatic, and colon cancers [51] [52] [53] . However, there were confl icting results regarding the prognostic value of MUC1, in part because of the use of different antibodies recognizing different glycoforms or different core peptides of MUC1 mucin, both of characteristics which can be modifi ed during carcinogenesis [54] . In the present study, we did not fi nd that MUC1 had a prognostic role in gastric cancer patients, a fi nding which is consistent with the results reported by Reis et al. [55] , but different from those reported by Utsunomiya et al. [56] and other authors [57] , who found that positive MUC1 expression was a marker of malignancy in gastric cancer.
It has been suggested that positivity for the gastric mucins (MUC5AC and MUC6) normally expressed in normal gastric epithelium, and/or positivity for intestinal mucin MUC2 is associated with a better prognosis in gastric adenocarcinoma [56, 58, 59 ]. Although we did not fi nd any signifi cant correlation between mucin expression and prognosis in our series, we observed that the positive expression of gastric mucins (MUC5AC and MUC6) and the intestinal mucin MUC2 was significantly more frequent in the young than in the older patients.
Some authors have suggested that MUC2 expression in tumors was correlated with lower levels of invasion and lymph node metastasis in gastric carcinomas [56] . Therefore, MUC2 expression may be inversely correlated with tumor aggressiveness in gastric carcinomas. Moreover, MUC2 expression has been related more specifi cally to the mucinous subtype of the WHO classifi cation, which was included in the diffuse-subtype group of Lauren's classifi cation in our series. In our series, we observed a higher percentage of MUC2 positivity in the young patient group, and we can associate this result as being due to the higher rate of diffuse-type tumor in this group.
In our casuistic, only 5.7% of all patients presented with MUC6 positivity. Other studies reported similar results [33, 60, 61] ; in contrast, however, other studies reported higher percentages for positivity [33] . The different results regarding the prognostic value of mucins may refl ect the use of different antibodies and also the score chosen for the mucin antigens (at least 10% of neoplastic cells stained). Our univariate analysis indicated that MUC6 positive expression was associated with a signifi cantly better survival rate, but the prognostic value of this marker was not confi rmed in the multivariate analysis.
We observed that alterations in E-cadherin/β-catenin adhesion complex expression and in the mucin (MUC2, MUC5AC and MUC6) expression occurred in a high percentage of gastric carcinomas in both groups of patients (≤40 years vs >40 years), but the older group displayed signifi cantly higher percentages of altered expression patterns. Considering our fi ndings, gastric carcinomas in young patients appear to have characteristics that are different from those of gastric carcinomas occurring at a later age [13, 15] ; the markers addressed in this study do not appear to play a predominant role in gastric carcinomas in young patients, considering that these patients displayed higher preservation of marker expression, and in addition, a better survival rate. Despite the signifi cant differences between the groups, the markers we tested were not signifi cant prognostic factors for patients with gastric carcinomas.
In our casuistic, when the overall survival analysis was restricted to the young patient group, none of the other factors except for the tumor stage, were found to have a prognostic signifi cance. The survival analysis for all patients was infl uenced by age, tumor stage, tumor location, tumor size, and lymph node involvement, as shown by the univariate analysis. However, the multivariate analysis indicated that age was not an independent factor for survival, in agreement with other studies [12, 62] . The pathological stage of gastric cancer remains the most important determinant of the prognosis.
The present study showed that the prognosis of gastric carcinoma is nearly always poor for both young and older groups of patients. Although only tumor stage persisted as an independent prognostic factor independent of the age of the patients, and age itself was not a prognostic factor, in our series there were signifi cant differences regarding clinicopathological parameters and marker expression patterns between the young and older patients. The young patients had a better survival rate and a higher percentage of marker expression preservation. Our fi ndings support the hypothesis that young patients develop carcinomas that have a different genetic pathway compared with that of tumors occurring at a later age. We suggest further investigations of these young patients to provide clues as to why they are different and to identify subgroups that would benefi t from screening and the detection of early disease. Further studies should also assess the prognostic relevance of the markers to specifi c patient groups.
